Epigenomics Enrolls First Participant in its FIT Comparative Study with Epi proColon®
OneMedRadio interviewed Thomas Taapken, CFO of Epigenomics, a Berlin based molecular diagnostics company for the early detection of cancer.
Articles by Herina Ayot
AVI Biopharma’s Chief Science Officer To Resign
Drug developer AVI Biopharma Inc. said Thursday that Chief Scientific Officer Peter Linsley will resign from the company.
March/April 2012
The OneMedResearch March/April 2012 Issue continues the discussion of 10 small companies with intriguing technology in an emerging market. This issue focuses its efforts on supplementing previous initiation […]
Editor’s Note April 10, 2012
This week, OneMedPlace brings you parts II and III on patent infringement highlighting two more cases changing the landscape. OneMedRadio brings you three interviews in this issue. Dr. Steve […]
ALS TDI -The First Non Profit Biotech, A Hidden Investment Opportunity?
Strategically, the organization has done a good job in moving drugs through clinical trials but lacks venture capital funding. But the benefit investors stand to gain is a major stakehold in the drug with a low investment.
May 1, 2012 Goldman Sachs Leveraged Finance Healthcare Conference
The Goldman Sachs Leveraged Finance Healthcare Conference 2012 to be held on Tuesday, May 1, 2012 will take place at the Goldman Sachs Conference Center, […]
Advaxis Nominated for Vaccine Industry Excellence Award
The company has been selected for the shortlist of the 5th Annual Vaccine Industry Excellence (ViE) Awards in the category of Best Therapeutic Vaccine.